Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Defence Therapeutics Inc (DTCFF)

Defence Therapeutics Inc (DTCFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Defence Therapeutics Announces Grant of Restricted Stock Units Newsfile - Fri Apr 24, 5:42PM CDT

Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics Announces Warrant Terms Amendment Newsfile - Fri Mar 20, 5:12PM CDT

Montreal, Quebec--(Newsfile Corp. - March 20, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000 Newsfile - Mon Mar 9, 2:16AM CDT

Montreal, Quebec--(Newsfile Corp. - March 9, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March Newsfile - Mon Mar 2, 2:20AM CST

Montreal, Quebec--(Newsfile Corp. - March 2, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company advancing next-generation...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million Newsfile - Fri Feb 27, 4:12PM CST

Montreal, Quebec--(Newsfile Corp. - February 27, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board Newsfile - Tue Feb 10, 2:18AM CST

Montreal, Quebec--(Newsfile Corp. - February 10, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform Newsfile - Wed Feb 4, 2:16AM CST

Montreal, Quebec--(Newsfile Corp. - February 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline Newsfile - Wed Jan 28, 7:52AM CST

Montreal, Quebec--(Newsfile Corp. - January 28, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics Newsfile - Wed Jan 21, 2:16AM CST

Montreal, Quebec--(Newsfile Corp. - January 21, 2026) - Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today announced...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)
Defence Therapeutics Announces AGM Results and Provides Corporate Updates Newsfile - Wed Dec 10, 2025

Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular...

DTCFF : 0.3652 (-8.59%)
DTC.CN : 0.5100 (+2.00%)

Barchart Exclusives

CVS Health Stock Breaks Out as Technical Indicators Turn Bright Green Barchart - 7 minutes ago
CVS Health (CVS) shares have reclaimed their 50-day moving average and are challenging their all-time high around $95 following an eight-month consolidation period. The stock currently maintains a 72% “Buy” technical opinion from Barchart, signaling strong alignment across short, medium, and long-term timeframes. This level for that indicator has been... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.